+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lipid Nanoparticle Market Size, Share & Trends Analysis Report by LNP (Liposomes, Nanostructured Lipid Carriers), Molecule (MRNA, SiRNA), Application, Indication, End Use, Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 6085878
Description Jump to:
The Lipid Nanoparticle Market was valued at USD 786.4 Million in 2024, and is projected to reach USD 1.54 Billion by 2030, rising at a CAGR of 13.64%. The lipid market has experienced significant growth driven by increasing demand for advanced drug delivery systems, particularly in the fields of gene therapy, oncology, and vaccines. LNPs offer a highly efficient method for encapsulating and delivering a wide range of therapeutic molecules-including mRNA, siRNA, and small molecules-directly to target cells with improved stability and reduced degradation. The surge in R&D activities and growing investment in nanomedicine by both public institutions and private players have played a critical role in supporting the widespread adoption of LNP-based drug formulations across the pharmaceutical and biotechnology sectors.

The development of COVID-19 vaccines that utilized LNP-based delivery systems for mRNA vaccines garnered significant attention and resources during the pandemic. This increased focus on vaccine delivery technologies has indirectly benefited the market by driving innovation and investment in LNP formulation and manufacturing capabilities. Regulatory agencies expedited the review and approval processes for COVID-19 therapeutics and vaccines, including those utilizing LNP technology. While this facilitated rapid market entry for COVID-19 treatments, it also underscored the need for streamlined regulatory pathways and standards for LNP-based products in other therapeutic areas, potentially shaping future regulatory frameworks and market dynamics.

Moreover, strategic collaborations, technological advancements in lipid formulation, and increased awareness of precision medicine continue to drive market growth. Companies are now investing in next-generation LNP platforms designed for targeted delivery, lower toxicity, and enhanced payload versatility. Innovations such as ionizable lipids, hybrid lipid-polymer systems, and surface modifications are expanding the scope of LNPs in treating complex diseases, including rare genetic disorders. These developments, coupled with a favorable regulatory landscape and rising demand for personalized treatments, are expected to sustain strong momentum in the market over the coming years.

Lipid Nanoparticle Market Report Highlights

  • Based on LNP, the liposomes segment dominated the overall market with the largest revenue share in 2024. Regulatory approvals of liposome-based drugs and their expanding use in cosmetic and nutraceutical applications continue to support market growth.
  • In terms of molecule, the mRNA segment dominated the overall market with the largest revenue share in 2024 and is expected to grow at the fastest CAGR during the forecast period. As pharmaceutical companies and biotech firms increasingly invest in mRNA therapeutics, the demand for optimized LNP delivery systems continues to rise, fueling market growth.
  • Therapeutics dominated the application segment in 2024 owing to the increasing collaborations between research institutions and industry players for drug development and growing government funding,
  • In 2024, cancer dominated the disease indication segment and is expected to witness a significant CAGR over the forecast period. The rising cancer burden and the potential of LNPs in cancer treatment are driving significant research and development efforts in this area.
  • Pharmaceutical & biotechnology companies dominated the end use segment and the academic & research institute segment is expected to register the fastest CAGR during the forecast period.
  • North America dominated the market in 2024 owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. LNP
1.2.2. Molecule
1.2.3. Application
1.2.4. Indication
1.2.5. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Growing Demand for Drug Delivery Systems
3.3.1.2. Rise in Pharmaceutical Research and Development
3.3.1.3. Increasing Focus on Nanotechnology
3.3.1.4. Government Support and Funding for RNA-based therapies
3.3.2. Market Restraint Analysis
3.3.2.1. High Development Costs
3.3.2.2. Stringent Regulations Related to Approval and Commercialization
3.4. Industry Analysis Tools
3.4.1. SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
3.4.2. Porter's Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Lipid Nanoparticle Market: LNP Business Analysis
4.1. Segment Dashboard
4.2. Global Lipid Nanoparticle Movement Analysis
4.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by LNP, 2018 to 2030 (USD Million)
4.4. Liposomes
4.4.1. Global Liposomes Market, 2018-2030 (USD Million)
4.5. Solid Lipid Nanoparticles
4.5.1. Global Solid Lipid Nanoparticles Market, 2018-2030 (USD Million)
4.6. Nanostructured Lipid Carriers
4.6.1. Global Nanostructured Lipid Carriers Market, 2018-2030 (USD Million)
4.7. Others
4.7.1. Global Others Market, 2018-2030 (USD Million)
Chapter 5. Lipid Nanoparticle Market: Molecule Business Analysis
5.1. Segment Dashboard
5.2. Global Lipid Nanoparticle Movement Analysis
5.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
5.4. siRNA
5.4.1. Global siRNA Market, 2018-2030 (USD Million)
5.5. mRNA
5.5.1. Global mRNA Market, 2018-2030 (USD Million)
5.6. Others
5.6.1. Global Others Market, 2018-2030 (USD Million)
Chapter 6. Lipid Nanoparticle Market: Application Business Analysis
6.1. Segment Dashboard
6.2. Global Lipid Nanoparticle Movement Analysis
6.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Therapeutics
6.4.1. Global Therapeutics Market, 2018-2030 (USD Million)
6.5. Research
6.5.1. Global Research Market, 2018-2030 (USD Million)
Chapter 7. Lipid Nanoparticle Market: Indication Business Analysis
7.1. Segment Dashboard
7.2. Global Lipid Nanoparticle Movement Analysis
7.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
7.4. Cancer
7.4.1. Global Cancer Market, 2018-2030 (USD Million)
7.5. Infectious Diseases
7.5.1. Global Infectious Diseases Market, 2018-2030 (USD Million)
7.6. Blood Diseases
7.6.1. Global Blood Diseases Market, 2018-2030 (USD Million)
7.7. Others
7.7.1. Global Others Market, 2018-2030 (USD Million)
Chapter 8. Lipid Nanoparticle Market: End Use Business Analysis
8.1. Segment Dashboard
8.2. Global Lipid Nanoparticle Movement Analysis
8.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Pharmaceutical & Biotechnology Companies
8.4.1. Global Pharmaceutical & Biotechnology Companies Market, 2018-2030 (USD Million)
8.5. Academic & Research Institutes
8.5.1. Global Academic & Research Institutes Market, 2018-2030 (USD Million)
8.6. Others
8.6.1. Global Others Market, 2018-2030 (USD Million)
Chapter 9. Lipid Nanoparticle Market: Regional Estimates & Trend Analysis by LNP, Molecule, Application, Indication, & End Use
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
9.3.1. North America Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.2. U.S.
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. Target Disease Prevalence
9.3.2.4. Regulatory Framework
9.3.2.5. U.S. Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.3. Canada
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Target Disease Prevalence
9.3.3.4. Regulatory Framework
9.3.3.5. Canada Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.4. Mexico
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Target Disease Prevalence
9.3.4.4. Regulatory Framework
9.3.4.5. Mexico Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4. Europe
9.4.1. Europe Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.2. UK
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Target Disease Prevalence
9.4.2.4. Regulatory Framework
9.4.2.5. UK Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.3. Germany
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Target Disease Prevalence
9.4.3.4. Regulatory Framework
9.4.3.5. Germany Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4. France
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Target Disease Prevalence
9.4.4.4. Regulatory Framework
9.4.4.5. France Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5. Italy
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Target Disease Prevalence
9.4.5.4. Regulatory Framework
9.4.5.5. Italy Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.6. Spain
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Target Disease Prevalence
9.4.6.4. Regulatory Framework
9.4.6.5. Spain Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.7. Denmark
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Target Disease Prevalence
9.4.7.4. Regulatory Framework
9.4.7.5. Denmark Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.8. Sweden
9.4.8.1. Key Country Dynamics
9.4.8.2. Competitive Scenario
9.4.8.3. Target Disease Prevalence
9.4.8.4. Regulatory Framework
9.4.8.5. Sweden Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.9. Norway
9.4.9.1. Key Country Dynamics
9.4.9.2. Competitive Scenario
9.4.9.3. Target Disease Prevalence
9.4.9.4. Regulatory Framework
9.4.9.5. Norway Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.2. Japan
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Target Disease Prevalence
9.5.2.4. Regulatory Framework
9.5.2.5. Japan Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.3. China
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Target Disease Prevalence
9.5.3.4. Regulatory Framework
9.5.3.5. China Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.4. India
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. Target Disease Prevalence
9.5.4.4. Regulatory Framework
9.5.4.5. India Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.5. Australia
9.5.5.1. Key Country Dynamics
9.5.5.2. Competitive Scenario
9.5.5.3. Target Disease Prevalence
9.5.5.4. Regulatory Framework
9.5.5.5. Australia Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key Country Dynamics
9.5.6.2. Competitive Scenario
9.5.6.3. Target Disease Prevalence
9.5.6.4. Regulatory Framework
9.5.6.5. Thailand Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.7. South Korea
9.5.7.1. Key Country Dynamics
9.5.7.2. Competitive Scenario
9.5.7.3. Target Disease Prevalence
9.5.7.4. Regulatory Framework
9.5.7.5. South Korea Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.6. Latin America
9.6.1. Latin America Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.2. Brazil
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Target Disease Prevalence
9.6.2.4. Regulatory Framework
9.6.2.5. Brazil Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Target Disease Prevalence
9.6.3.4. Regulatory Framework
9.6.3.5. Argentina Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.7. MEA
9.7.1. MEA Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.2. South Africa
9.7.2.1. Key Country Dynamics
9.7.2.2. Competitive Scenario
9.7.2.3. Target Disease Prevalence
9.7.2.4. Regulatory Framework
9.7.2.5. South Africa Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key Country Dynamics
9.7.3.2. Competitive Scenario
9.7.3.3. Target Disease Prevalence
9.7.3.4. Regulatory Framework
9.7.3.5. Saudi Arabia Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.4. UAE
9.7.4.1. Key Country Dynamics
9.7.4.2. Competitive Scenario
9.7.4.3. Target Disease Prevalence
9.7.4.4. Regulatory Framework
9.7.4.5. UAE Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key Country Dynamics
9.7.5.2. Competitive Scenario
9.7.5.3. Target Disease Prevalence
9.7.5.4. Regulatory Framework
9.7.5.5. Kuwait Lipid nanoparticle market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Merck KGaA
10.4.1.1. Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Evonik Industries AG
10.4.2.1. Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Gattefosse
10.4.3.1. Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. FUJIFILM Pharmaceutical
10.4.4.1. Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Danaher (Precision NanoSystems)
10.4.5.1. Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Creative Biolabs
10.4.6.1. Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. IOI Oleo GmbH
10.4.7.1. Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. NOF Corporation
10.4.8.1. Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Lipoid GmbH
10.4.9.1. Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Cyman Chemical
10.4.10.1. Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 4 Global lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 5 Global lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 6 Global lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 7 Global lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 8 Global lipid nanoparticle market, by region, 2018-2030 (USD Million)
Table 9 North America lipid nanoparticle market, by country, 2018-2030 (USD Million)
Table 10 North America lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 11 North America lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 12 North America lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 13 North America lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 14 North America lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 15 U.S. lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 16 U.S. lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 17 U.S. lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 18 U.S. lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 19 U.S. lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 20 Canada lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 21 Canada lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 22 Canada lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 23 Canada lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 24 Canada lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 25 Mexico lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 26 Mexico lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 27 Mexico lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 28 Mexico lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 29 Mexico lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 30 Europe lipid nanoparticle market, by country, 2018-2030 (USD Million)
Table 31 Europe lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 32 Europe lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 33 Europe lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 34 Europe lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 35 Europe lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 36 UK lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 37 UK lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 38 UK lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 39 UK lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 40 UK lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 41 Germany lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 42 Germany lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 43 Germany lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 44 Germany lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 45 Germany lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 46 France lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 47 France lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 48 France lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 49 France lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 50 France lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 51 Italy lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 52 Italy lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 53 Italy lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 54 Italy lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 55 Italy lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 56 Spain lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 57 Spain lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 58 Spain lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 59 Spain lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 60 Spain lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 61 Denmark lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 62 Denmark lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 63 Denmark lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 64 Denmark lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 65 Denmark lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 66 Sweden lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 67 Sweden lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 68 Sweden lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 69 Sweden lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 70 Sweden lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 71 Norway lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 72 Norway lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 73 Norway lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 74 Norway lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 75 Norway lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 76 Asia Pacific lipid nanoparticle market, by country, 2018-2030 (USD Million)
Table 77 Asia Pacific lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 78 Asia Pacific lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 79 Asia Pacific lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 80 Asia Pacific lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 81 Asia Pacific lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 82 Japan lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 83 Japan lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 84 Japan lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 85 Japan lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 86 Japan lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 87 China lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 88 China lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 89 China lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 90 China lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 91 China lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 92 India lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 93 India lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 94 India lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 95 India lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 96 India lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 97 Australia lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 98 Australia lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 99 Australia lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 100 Australia lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 101 Australia lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 102 Thailand lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 103 Thailand lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 104 Thailand lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 105 Thailand lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 106 Thailand lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 107 South Korea lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 108 South Korea lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 109 South Korea lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 110 South Korea lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 111 South Korea lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 112 Latin America lipid nanoparticle market, by country, 2018-2030 (USD Million)
Table 113 Latin America lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 114 Latin America lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 115 Latin America lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 116 Latin America lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 117 Latin America lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 118 Brazil lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 119 Brazil lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 120 Brazil lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 121 Brazil lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 122 Brazil lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 123 Argentina lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 124 Argentina lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 125 Argentina lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 126 Argentina lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 127 Argentina lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 128 Middle East & Africa lipid nanoparticle market, by country, 2018-2030 (USD Million)
Table 129 Middle East & Africa lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 130 Middle East & Africa lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 131 Middle East & Africa lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 132 Middle East & Africa lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 133 Middle East & Africa lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 134 South Africa lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 135 South Africa lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 136 South Africa lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 137 South Africa lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 138 South Africa lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 139 Saudi Arabia lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 140 Saudi Arabia lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 141 Saudi Arabia lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 142 Saudi Arabia lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 143 Saudi Arabia lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 144 UAE lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 145 UAE lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 146 UAE lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 147 UAE lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 148 UAE lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 149 Kuwait lipid nanoparticle market, by LNP, 2018-2030 (USD Million)
Table 150 Kuwait lipid nanoparticle market, by application, 2018-2030 (USD Million)
Table 151 Kuwait lipid nanoparticle market, by molecule, 2018-2030 (USD Million)
Table 152 Kuwait lipid nanoparticle market, by indication, 2018-2030 (USD Million)
Table 153 Kuwait lipid nanoparticle market, by end use, 2018-2030 (USD Million)
Table 154 Participant's overview
Table 155 Financial performance
Table 156 Key companies undergoing expansions
Table 157 Key companies undergoing acquisitions
Table 158 Key companies undergoing collaborations
Table 159 Key companies launching new products
Table 160 Key companies undertaking other strategies
List of Figures
Figure 1 Lipid nanoparticle market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Parent market outlook
Figure 13 Related/ancillary market outlook
Figure 14 Genomics - Industry value chain analysis
Figure 15 Lipid nanoparticle market driver analysis
Figure 16 Lipid nanoparticle market restraint analysis
Figure 17 Lipid nanoparticle market: Porter's analysis
Figure 18 Lipid nanoparticle market: LNP outlook and key takeaways
Figure 19 Lipid nanoparticle market: LNP market share analysis, 2023-2030
Figure 20 Global lipid nanoparticle by liposomes market, 2018-2030 (USD Million)
Figure 21 Global lipid nanoparticle by solid lipid nanoparticles market, 2018-2030 (USD Million)
Figure 22 Global lipid nanoparticle by nanostructured lipid carriers market, 2018-2030 (USD Million)
Figure 23 Global lipid nanoparticle by others market, 2018-2030 (USD Million)
Figure 24 Lipid nanoparticle market: Molecule outlook and key takeaways
Figure 25 Lipid nanoparticle market: Molecule market share analysis, 2023-2030
Figure 26 Global lipid nanoparticle by siRNA market, 2018-2030 (USD Million)
Figure 27 Global lipid nanoparticle by mRNA market, 2018-2030 (USD Million)
Figure 28 Global lipid nanoparticle by others market, 2018-2030 (USD Million)
Figure 29 Lipid nanoparticle market: Application outlook and key takeaways
Figure 30 Lipid nanoparticle market: Application market share analysis, 2023-2030
Figure 31 Global lipid nanoparticle by therapeutics market, 2018-2030 (USD Million)
Figure 32 Global lipid nanoparticle by research market, 2018-2030 (USD Million)
Figure 33 Lipid nanoparticle market: Indication outlook and key takeaways
Figure 34 Lipid nanoparticle market: Indication market share analysis, 2023-2030
Figure 35 Global lipid nanoparticle by cancer market, 2018-2030 (USD Million)
Figure 36 Global lipid nanoparticle by infectious diseases market, 2018-2030 (USD Million)
Figure 37 Global lipid nanoparticle by blood diseases market, 2018-2030 (USD Million)
Figure 38 Global lipid nanoparticle by others market, 2018-2030 (USD Million)
Figure 39 Lipid nanoparticle market: End user outlook and key takeaways
Figure 40 Lipid nanoparticle market: end user market share analysis, 2023-2030
Figure 41 Global lipid nanoparticle by pharmaceutical & biotechnology companies market, 2018-2030 (USD Million)
Figure 42 Global lipid nanoparticle by academic & research institutes market, 2018-2030 (USD Million)
Figure 43 Global lipid nanoparticle by others market, 2018-2030 (USD Million)
Figure 44 Regional marketplace: Key takeaways
Figure 45 North America lipid nanoparticle market estimates and forecast, 2018-2030 (USD Million)
Figure 46 U.S. key country dynamics
Figure 47 U.S. lipid nanoparticle market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Canada key country dynamics
Figure 49 Canada lipid nanoparticle market, 2018-2030 (USD Million)
Figure 50 Mexico key country dynamics
Figure 51 Mexico lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 52 Europe lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 53 UK key country dynamics
Figure 54 UK lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 55 Germany key country dynamics
Figure 56 Germany lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 57 France key country dynamics
Figure 58 France lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 59 Italy key country dynamics
Figure 60 Italy lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 61 Spain key country dynamics
Figure 62 Spain lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 63 Denmark key country dynamics
Figure 64 Denmark lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 65 Sweden key country dynamics
Figure 66 Sweden lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 67 Norway key country dynamics
Figure 68 Norway lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 69 Asia-Pacific lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 70 Japan key country dynamics
Figure 71 Japan lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 72 China key country dynamics
Figure 73 China lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 74 India key country dynamics
Figure 75 India lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 76 Australia key country dynamics
Figure 77 Australia lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 78 Thailand key country dynamics
Figure 79 Thailand lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 80 South Korea key country dynamics
Figure 81 South Korea lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 82 Latin America lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 83 Brazil key country dynamics
Figure 84 Brazil lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 85 Argentina key country dynamics
Figure 86 Argentina lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 87 MEA lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 88 South Africa key country dynamics
Figure 89 South Africa lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 90 Saudi Arabia key country dynamics
Figure 91 Saudi Arabia lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 92 UAE key country dynamics
Figure 93 UAE lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 94 Kuwait key country dynamics
Figure 95 Kuwait lipid nanoparticle market estimates and forecast, 2018-2030 (USD million)
Figure 96 Key company categorization
Figure 97 Company market positioning
Figure 98 Market participant categorization
Figure 99 Strategy framework

Companies Mentioned

The companies profiled in this Lipid Nanoparticle market report include:
  • Merck KGaA
  • Evonik Industries AG
  • Gattefosse
  • FUJIFILM Pharmaceutical
  • Danaher (Precision NanoSystems)
  • Creative Biolabs
  • IOI Oleo GmbH
  • NOF Corporation
  • Lipoid GmbH
  • Cyman Chemical

Related Topics

Related Reports

Lipid Nanoparticle Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Lipid Nanoparticle, Type of Molecule Delivered, Company Size, Target Therapeutic Area, Type of End-user and Key Geographical Regions - Product Image

Lipid Nanoparticle Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Lipid Nanoparticle, Type of Molecule Delivered, Company Size, Target Therapeutic Area, Type of End-user and Key Geographical Regions

  • Report
  • 290 Pages
  • Global
From
Lipid Nanoparticles Market by Product (Ionizable Lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (SiRNA, MRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029 - Product Image

Lipid Nanoparticles Market by Product (Ionizable Lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (SiRNA, MRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029

  • Report
  • 317 Pages
  • Global
From
Lipid Nanoparticle Raw Materials - Global Strategic Business Report - Product Image

Lipid Nanoparticle Raw Materials - Global Strategic Business Report

  • Report
  • 72 Pages
  • Global
From
Lipid Nanoparticle Market Share Analysis and Size - Growth Trends and Forecast Report 2025-2033 - Product Image

Lipid Nanoparticle Market Share Analysis and Size - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Lipid Nanoparticles Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Lipid Nanoparticles Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.